Brain Tumor and Neuro-Oncology Center - Cleveland Clinic

4
Executive Summary
Cleveland Clinic Brain Tumor and Neuro-Oncology
Center enjoyed a year of substantial accomplishment
in 2008.
Record-Setting Clinical and Financial Performance:
• 7,943 outpatient visits
• 936 surgical, Gamma Knife ® and Novalis ® procedures
• Increase of 150% new patient visits, 366% total
outpatient visits, 23% surgical cases and 91%
Gamma Knife cases since program’s inception
in 2001
• Largest market share in Ohio
• 21% increase in net revenue and 85% increase
in contribution margin over 2007
Solid Research Revenue and Philanthropic Support:
• Funding through three federal grants
• $1.5M in philanthropic support since 2007 and
$14.6M since inception
Pace-Setting Clinical Programs:
• World’s first human treatment of brain tumor using
AutoLITT ® thermal therapy system (see cover figure)
• Advance navigation using DTI and fMRI planning
and intraoperative visualizations
• Compact MRI with development of high-field
interventional MRI operating room
• Leader in convection-enhanced delivery of advanced
agents to brain tumors
• Second Gamma Knife Perfexion unit in North
America – 317 cases in 2008
• Leader in spinal radiosurgery – 74 procedures
performed in 2008, and more than 200 cases
since program inception in 2004
• Integration of neuropsychology into clinical program
BRAIN TUMOR AND NEURO-ONCOLOGY CENTER
Robust Clinical Research:
• Completing membership in NCI-sponsored New
Approaches to Brain Tumor Therapy (NABTT)
consortium
• Charter member of NCI-sponsored Adult Brain
Tumor Consortium (ABTC), commencing in 2009
• Leadership in national brain tumor organizations
• Dr. Vogelbaum Scientific Program Chair of 2008
Society of Neuro-Oncology Meeting
Laboratory Research:
• Recruitment of Jeremy Rich, MD, as Chair of
Genomics Institute. Dr. Rich, a world-renowned
expert on brain tumor stem cells, joined the
professional staff in September 2008.
• Recruitment of Candece Gladson, PhD, as
Head of Brain Tumor Laboratory Research in the
Department of Cancer Biology of Cleveland Clinic
Lerner Research Institute. Dr. Gladson joined the
staff in January 2009.
• Primary labs and collaborations performing cuttingedge
basic and translational research
Education – Local, Regional, National and
International Presence:
• Hosted Second International Symposium on
Stereotactic Body Radiation Therapy and
Stereotactic Radiosurgery
• Hosted Pituitary Disease Symposium in April
• Hosted joint meeting with Mexican Neurosurgical
and Neuro-Oncology Societies in November at
Los Cabos, Mexico
• Hosted four Gamma Knife hands-on courses
Publishing Our Accomplishments:
• BTNC staff published 38 journal articles and
two book chapters in 2008